Adult liver transplantation in the United States

American Journal of the Medical Sciences

Volumn 343, Issue 6, 2012, Pages 462-469

  Bachir, Natalie M ^a   Larson, Anne M ^b  

^a Duluth Clinic   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Indications; Liver transplantation; Outcomes.

Indexed keywords

BILIRUBIN; CREATININE;

ACUTE LIVER FAILURE; ANTIVIRAL THERAPY; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CHRONIC LIVER FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INTERACTION; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INSULIN RESISTANCE; INTERNATIONAL NORMALIZED RATIO; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; NEOPLASM; NEUROENDOCRINE TUMOR; OBESITY; RECURRENT DISEASE; RETRANSPLANTATION; SEX DIFFERENCE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED STATES;

EID: 84862856532     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182308b66     Document Type: Article

References (40)

1. National Institutes of Health Consensus Development Conference Statement: liver transplantation-June 20-23, 1983. Hepatology 1984;4 (1 suppl):107S-10S.
2. Starzl TE, Marchioro TL, Vonkaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-76.
3. Shapiro HA. Brain death and organ transplantation. J Forensic Med 1968;15:89-90.
4. Starzl TE, Ishikawa M, Putnam CW, et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974;6(4 suppl. 1):129-39.
5. National Organ Transplant Act: Public Law 98-507. US Statute Large 1984;(42 USC Sec. 273):2399-48.
6. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9. (Pubitemid 26079803)
7. Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003;21:4329-35. (Pubitemid 46621808)
8. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403. (Pubitemid 32496976)
9. Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int 2010;23:692-7.
10. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-32. (Pubitemid 40770295)
11. Hirschfield GM, Gibbs P, Griffiths WJ. Adult liver transplantation: what non-specialists need to know. BMJ 2009;338:1321-7.
12. Dawwas MF, Gimson AE. Candidate selection and organ allocation in liver transplantation. Semin Liver Dis 2009;29:40-52.
13. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-13. (Pubitemid 40179517)
14. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
15. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71. (Pubitemid 30169932)
16. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903. (Pubitemid 38670122)
17. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805. (Pubitemid 46450631)
18. Brown RS Jr, Lake JR. The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant 2005;5:203-4. (Pubitemid 40179505)
19. Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008;300:2371-8.
20. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41:32-9. (Pubitemid 40066380)
21. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-26.
22. Neuberger J, Gimson A, Davies M, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008;57: 252-7. (Pubitemid 351158055)
23. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-63. (Pubitemid 36874450)
24. Freise CE, Gillespie BW, Koffron AJ, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant 2008;8: 2569-79.
25. Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990;322:1505-7. (Pubitemid 20179865)
26. Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004;10:1263-8. (Pubitemid 39406081)
27. Marcos A, Fisher RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-9. (Pubitemid 30238727)
28. Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008;135:468-76.
29. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-90. (Pubitemid 43345017)
30. Groth CG. Forty years of liver transplantation: personal recollections. Transplant Proc 2008;40:1127-9. (Pubitemid 351794284)
31. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. (Pubitemid 34267271)
32. Narang TK, Ahrens W, Russo MW. Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria. Liver Transpl 2010;16: 1228-35.
33. Lucey MR. Liver transplantation for alcoholic liver disease. Clin Liver Dis 2007;11:283-9. (Pubitemid 46990960)
34. Bellamy CO, DiMartini AM, Ruppert K, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001;72:619-26. (Pubitemid 32802742)
35. Watt KD. Obesity and metabolic complications of liver transplantation. Liver Transpl 2010;16:S65-71.
36. Kuo HT, Sampaio MS, Ye X, et al. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 2010;89:1134-40.
37. Sharma P, Welch K, Eikstadt R, et al. Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl 2009;15:1142-8.
38. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490-500.
39. Onaca N, Levy MF, Ueno T, et al. An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int 2006;19:282-7.
40. Alexander SI,SmithN,HuM, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008;358:369-74. (Pubitemid 351159236)